申请人:American Home Products Corporation
公开号:US20010020037A1
公开(公告)日:2001-09-06
This invention provides compounds of Formula I having the structure
1
wherein
B and D are each, independently, hydrogen, halogen, —CN, alkyl of 1-6 carbon atoms, aryl, or aralkyl of 6-12 carbon atoms;
R
1
is hydrogen, alkyl of 1-6 carbon atoms, —CH(R
2
)W, —C(CH
3
)
2
CO
2
R
3
, 5-thiazolidine-2,4-dione, —CH(R
4
)CH
2
CO
2
R
3
, —COR
3
, or —PO
3
(R
3
)
2
;
R
2
is hydrogen, alkyl of 1-6 carbon atoms, aralkyl of 6-12 carbon atoms, aryl, —CH
2
(1H-imidazol-4-yl), —CH
2
(3-1H-indolyl), —CH
2
CH
2
(1,3-dioxo-1,3-dihydro-isoindol-2-yl), —CH
2
CH
2
(1-oxo-1,3-dihydro-isoindol-2-yl), or —CH
2
(3-pyridyl);
W is —CO
2
R
3
, —CONH
2
, —CONHOH, —CN, CONH(CH
2
)
2
CN, 5-tetrazole, or —PO
3
(R
3
)
2
;
R
3
is hydrogen, alkyl of 1-6 carbon atoms, or, aryl;
R
4
is hydrogen or alkyl of 1-6 carbon atoms;
or a pharmaceutically acceptable salt thereof, which are useful in treating, metabolic disorders related to insulin resistance or hyperglycemia.
本发明提供了式I的化合物,其结构为1其中B和D各自独立地为氢、卤素、—CN、1-6个碳原子的烷基、芳基或6-12个碳原子的芳基烷基;R1为氢、1-6个碳原子的烷基、—CH(R2)W、—C(
CH3)2CO2R3、5-
噻唑烷-2,4-二酮、—CH(R4) CO2R3、—COR3或—PO3(R3)2;R2为氢、1-6个碳原子的烷基、6-12个碳原子的芳基烷基、芳基、—
CH2(
1H-咪唑-4-基)、— (3-1H-
吲哚基)、— (1,3-二氢-2-氮杂-异
吲哚-2-基)、— (1-氧代-1,3-二氢-异
吲哚-2-基)或— (3-
吡啶基);W为—CO2R3、—CONH2、—CONHOH、—CN、CONH( )2CN、5-
四唑或—PO3(R3)2;R3为氢、1-6个碳原子的烷基或芳基;R4为氢或1-6个碳原子的烷基;或其药学上可接受的盐,用于治疗与
胰岛素抵抗或高血糖有关的代谢紊乱。